SPECIAL: Standard or PalliativE Care In Advanced Lung cancer
Does early referral of patients with metastatic non-small cell lung cancer to UK specialist palliative care services make a difference in their quality of life or survival?
| Chief Investigators:
||Emeritus Professor Sam H Ahmedzai
||Sheffield Teaching Hospital NHS Foundation Trust
||NIHR Health Technology Assessment Programme
| Disease Site:
||Lung; Specialist palliative care
| Trial Type:
||Non-Investigational Medicinal Product (ie. non-IMP or non-CTIMP), observational study
| UKCRN Study ID:
| ISRCTN Referance Number:
| Open to New Sites?
| Recruitment Start Date:
| Recruitment End Date:
|CRCTU Trial Management Team:
|| Late Phase Trial Management Team - A
|Trial Email Address:
SPECIAL was a randomised trial with an integral (non-randomised) observational feasibility study looking at current standard referral practices for patients newly diagnosed with stage IV non-small cell lung cancer to palliative care specialists/teams. The trial closed during the feasibility stage.
Please note that the trials team cannot give individual’s clinical advice. Patients and their families should contact their treating physician to discuss trials for which they may be eligible
Clinical trial protocols are complex technical documents which should only be used for the treatment of subjects taking part in the trial.
The trial in now closed.